Profile of:
Maria Konsta
Professional career • 1995- 2002: Medical School, University of Athens, Greece (Grade:7.28 /10) • 2005- 2008:Master Diplom -MSc in Biostatistic (Grade:8.59/10, Excellent) • 2008- 2010:Residency in Rheumatology (1st year), Veterans Administration Hospital, Rheumatology Department, Athens, Greece (Director: Alexios Iliopoulos,MD) • 2011-2014: Resident in Rheumatology, Rheumatology Department of 1st Internal Medicine Clinic, Medical School, University of Athens, Laikon Hospital, Greece. • July 2014:Obtain the Specialty of Rheumatology (successfully passed the board exams) • 2011-2016:PhD: Rheumatology Department of 1st Propaedeutic Internal Medicine Clinic, Medical School, University of Athens.Dissertation title: “Biomarkers of radiographic progression in Ankylosing Spondylitis”, (Grade: Excellent). Supervisor: Prof. Petros P. Sfikakis • October 2015-April 2016:Traineeship in SpA. Guest researcher in Rheumatology Clinic of Vrije Universiteit medical center (VUmc), Amsterdam, the Netherlands, Supervisor: dr. Irene van der Horst-Bruinsma (EULAR bursary & grant from Greek Rheumatology Society) • 2015-2017:Private Practice,Consultant Rheumatologist at Private Clinic «Hippocrates» • 2017-2019:Consultant Rheumatologist at Outpatient Clinic "Alexandra Health Centre" • 2019-2020:Private Practice • October 2020-April 2021:Consultant Rheumatologist at Outpatient Clinic "Patision Health Centre" • April 2021-ongoing:Consultant Rheumatologist, "Sismanoglion" hospital
Full name: Maria Konsta
Current country: Greece
Membership level: Associate
Type of membership: Member
Number of publications: 15
Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels (2021)
https://pubmed.ncbi.nlm.nih.gov/33278588/
Anterior chest wall involvement in psoriatic arthritis: a forgotten entity? (2020)
https://pubmed.ncbi.nlm.nih.gov/32277826/
Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30690799/
Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters (2017)
https://pubmed.ncbi.nlm.nih.gov/27369645/
Osteoporosis and vascular calcification in postmenopausal women: a cross-sectional study (2016)
https://pubmed.ncbi.nlm.nih.gov/27045323/
Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies (2015)
https://pubmed.ncbi.nlm.nih.gov/26428207/
Atrial fibrillation following intravenous zolendronic acid for osteoporosis (2014)
https://pubmed.ncbi.nlm.nih.gov/24847757/
Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis (2013)
https://pubmed.ncbi.nlm.nih.gov/23604596/
Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis (2013)
https://pubmed.ncbi.nlm.nih.gov/23204549/
B12 deficiency myelopathy in a patient with long-standing rheumatoid arthritis (2012)
https://pubmed.ncbi.nlm.nih.gov/23013852/
Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis (2012)
https://pubmed.ncbi.nlm.nih.gov/22133618/
Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation (2012)
https://pubmed.ncbi.nlm.nih.gov/22280512/
H1N1 influenza outcome in rheumatic patients under biological therapy (2012)
https://pubmed.ncbi.nlm.nih.gov/22409960/
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis (2011)
https://pubmed.ncbi.nlm.nih.gov/22032557/
Cryptogenic organizing pneumonia mimicking malignancy in a patient with rheumatoid arthritis (2011)
https://pubmed.ncbi.nlm.nih.gov/21885507/
